- |||||||||| Trial completion, Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=629, Completed,
N=300 --> 40 Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2014
- |||||||||| Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=629, Active, not recruiting,
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2014 Trial primary completion date: Mar 2016 --> Sep 2016
- |||||||||| acetylcysteine solution / Generic mfg.
Enrollment change, Trial termination: A Clinical Trial for CTD-ILD Treatment (clinicaltrials.gov) - Feb 13, 2016
P2/3, N=5, Terminated,
Trial primary completion date: Mar 2016 --> Sep 2016 N=20 --> 5 | Recruiting --> Terminated; Departure of study team
- |||||||||| Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=629, Active, not recruiting,
N=20 --> 5 | Recruiting --> Terminated; Departure of study team Trial primary completion date: Sep 2015 --> Mar 2016
- |||||||||| Trial completion: The CARRA Registry (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=9587, Completed,
Trial primary completion date: Sep 2015 --> Mar 2016 Enrolling by invitation --> Completed
- |||||||||| Enrollment closed, Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Apr 30, 2015
P=N/A, N=629, Active, not recruiting,
Enrolling by invitation --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Sep 2015
- |||||||||| Enrollment status: The CARRA Registry (clinicaltrials.gov) - Apr 23, 2015
P=N/A, N=10000, Enrolling by invitation,
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Sep 2015 Recruiting --> Enrolling by invitation
- |||||||||| acetylcysteine solution / Generic mfg.
Enrollment open: A Clinical Trial for CTD-ILD Treatment (clinicaltrials.gov) - Dec 4, 2011
P2/3, N=20, Recruiting,
Recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
|
